About: Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic
Creator	Ryan, John Chakinala, Murali Gomberg-Maitland, Mardi Melendres-Groves, Lana Oudiz, Ronald Rosenzweig, Erika Zamanian, Roham
Source	Medline; PMC; WHO
abstract	The COVID-19 pandemic presents many unique challenges when caring for patients with pulmonary hypertension. The COVID-19 pandemic has altered routine standard of care practice and the acute management particularly for those patients with pulmonary arterial hypertension, where pulmonary arterial hypertension-specific treatments are used. It is important to balance the ongoing care and evaluation of pulmonary arterial hypertension patients with “exposure risk” to COVID-19 for patients coming to clinic or the hospital. If there is a morbidity and mortality benefit from starting pulmonary arterial hypertension therapies, for example in a patient with high-likelihood of pulmonary arterial hypertension, then it remains important to complete the thorough evaluation. However, the COVID-19 outbreak may also represent a unique time when pulmonary hypertension experts have to weigh the risks and benefits of the diagnostic work-up including potential exposure to COVID-19 versus initiating targeted pulmonary arterial hypertension therapy in a select high-risk, high likelihood World Symposium Pulmonary Hypertension Group 1 pulmonary arterial hypertension patients. This document will highlight some of the issues facing providers, patients, and the pulmonary arterial hypertension community in real-time as the COVID-19 pandemic is evolving and is intended to share expected common clinical scenarios and best clinical practices to help the community at-large.
has issue date	2020-04-29(xsd:dateTime)
bibo:doi	10.1177/2045894020920153
bibo:pmid	32426111
has license	cc-by-nc
sha1sum (hex)	81a944179c79a5bec0a81d4718b40b4ab378bff9
schema:url	https://doi.org/10.1177/2045894020920153
resource representing a document's title	Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic
has PubMed Central identifier	PMC7222260
has PubMed identifier	32426111
schema:publication	Pulm Circ
resource representing a document's body	covid:81a944179c79a5bec0a81d4718b40b4ab378bff9#body_text
is schema:about of	named entity 'risks' named entity 'patients' named entity 'pulmonary hypertension' named entity 'targeted' named entity 'expected' named entity 'time' named entity 'care' named entity 'high' named entity 'presents' named entity 'care' named entity 'altered' named entity 'morbidity' named entity 'standard of care' named entity 'pulmonary hypertension' named entity 'pulmonary arterial hypertension' named entity 'at-large' named entity 'patient' named entity 'systemic infection' named entity 'infection' named entity 'RHF' named entity 'echocardiography' named entity 'patient care' named entity 'infection' named entity 'intensive care units' named entity 'Bayer' named entity 'PAH' named entity 'PAH' named entity 'COVID-19 pandemic' named entity 'immunosuppressive agents' named entity 'PAH' named entity 'COVID' named entity 'infection' named entity 'health care' named entity 'COVID' named entity 'NT-proBNP' named entity 'PAH' named entity 'selexipag' named entity 'chronic respiratory disease' named entity 'COVID-19' named entity 'cough' named entity 'fever' named entity 'prognosis' named entity 'viral infection' named entity 'heart catheterization' named entity 'ECMO' named entity 'Bayer' named entity 'CVD' named entity 'PAH' named entity 'COVID' named entity 'RHF' named entity 'Actelion' named entity 'Arena Pharmaceuticals' named entity 'RHF' named entity 'ARDS' named entity 'COVID-19 pandemic' named entity 'China' named entity 'telehealth' named entity 'bacterial infection' named entity 'physiology' named entity 'RHF' named entity 'good clinical practice' named entity 'PAH' named entity 'differential diagnosis' named entity 'PAH' named entity 'surgical intervention' named entity 'PAH' named entity 'Actelion' named entity 'COVID-19 pandemic' named entity 'extubation' named entity 'all-cause' named entity 'riociguat' named entity 'ventilatory support' named entity 'pulmonary hypertension' named entity 'PAH' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software